These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33338704)

  • 41. Systemic Inflammation Indices in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator: Clinical Yield and Utility.
    Topcuoglu MA; Pektezel MY; Yilmaz E; Arsava EM
    Angiology; 2021 Mar; 72(3):279-284. PubMed ID: 33153275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Impact of Discrepancy between Measured versus Stated Weight on Hemorrhagic Transformation and Clinical Outcomes after Intravenous Alteplase Thrombolysis.
    Shin DH; Kang MJ; Kim JW; Shin DJ; Park HM; Sung YH; Kim EY
    Cerebrovasc Dis; 2017; 44(5-6):241-247. PubMed ID: 28848080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of rt-PA intravenous thrombolysis on the prognosis of patients with minor ischemic stroke.
    Han Y; Li G; Tang Y; Zhang B; Zhan Y; Zhang C; Zuo L; Wu W
    Neurol Res; 2021 Aug; 43(8):653-658. PubMed ID: 33847231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of changes in platelet-to-neutrophil ratios 24 hours after intravenous thrombolysis on prognosis in acute ischemic stroke patients.
    Pan H; Fu M; Ge W; Zhou C
    Clin Neurol Neurosurg; 2020 Mar; 190():105739. PubMed ID: 32105907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin resistance is associated with a poor response to intravenous thrombolysis in acute ischemic stroke.
    Calleja AI; García-Bermejo P; Cortijo E; Bustamante R; Rojo Martínez E; González Sarmiento E; Fernández-Herranz R; Arenillas JF
    Diabetes Care; 2011 Nov; 34(11):2413-7. PubMed ID: 21911778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18-64 years in the USA.
    Joo H; Wang G; George MG
    Stroke Vasc Neurol; 2016 Mar; 1(1):8-15. PubMed ID: 27547449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.
    Schellinger PD; Jansen O; Fiebach JB; Heiland S; Steiner T; Schwab S; Pohlers O; Ryssel H; Sartor K; Hacke W
    Stroke; 2000 Jun; 31(6):1318-28. PubMed ID: 10835451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benefits of intravenous thrombolysis in acute ischemic stroke related to extra cranial internal carotid dissection. Dream or reality?
    Fuentes B; Masjuan J; Alonso de Leciñana M; Simal P; Egido J; Díaz-Otero F; Gil-Nuñez A; Martínez-Sánchez P; Díez-Tejedor E;
    Int J Stroke; 2012 Jan; 7(1):7-13. PubMed ID: 22017881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation.
    Horsch AD; Bennink E; van Seeters T; Kappelle LJ; van der Graaf Y; Mali WPTM; de Jong HWAM; Velthuis BK; Dankbaar JW;
    Cerebrovasc Dis; 2018; 45(1-2):26-32. PubMed ID: 29402765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Higher Left Ventricle Mass Indices Predict Favorable Outcome in Stroke Patients with Thrombolysis.
    Wu F; Cao W; Ling Y; Yang L; Cheng X; Dong Q
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1609-13. PubMed ID: 25959501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J; Sabovic M; Frol S
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
    Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort.
    Ornello R; Foschi M; De Santis F; Romoli M; Tassinari T; Saia V; Cenciarelli S; Bedetti C; Padiglioni C; Censori B; Puglisi V; Vinciguerra L; Guarino M; Barone V; Zedde M; Grisendi I; Diomedi M; Bagnato MR; Petruzzellis M; Mezzapesa DM; Di Viesti P; Inchingolo V; Cappellari M; Zivelonghi C; Candelaresi P; Andreone V; Rinaldi G; Bavaro A; Cavallini A; Moraru S; Querzani P; Terruso V; Mannino M; Pezzini A; Frisullo G; Muscia F; Paciaroni M; Mosconi MG; Zini A; Leone R; Palmieri C; Cupini LM; Marcon M; Tassi R; Sanzaro E; Paci C; Viticchi G; Orsucci D; Falcou A; Beretta S; Tarletti R; Nencini P; Rota E; Sepe FN; Ferrandi D; Caputi L; Volpi G; La Spada S; Beccia M; Rinaldi C; Mastrangelo V; Di Blasio F; Invernizzi P; Pelliccioni G; De Angelis MV; Bonanni L; Ruzza G; Caggia EA; Russo M; Tonon A; Acciarri MC; Anticoli S; Roberti C; Manobianca G; Scaglione G; Pistoia F; Fortini A; De Boni A; Sanna A; Chiti A; Barbarini L; Caggiula M; Masato M; Del Sette M; Passarelli F; Bongioanni MR; Toni D; Ricci S; De Matteis E; Sacco S;
    J Am Heart Assoc; 2024 Aug; 13(16):e036275. PubMed ID: 39119964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated plasma fibrinogen indicates short-term poor outcome in patients with acute ischemic stroke after intravenous thrombolysis.
    Li D; Xing C; Li Y; Zhu X
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104991. PubMed ID: 32689615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Stroke Outcomes of Hub and Spoke Hospital Treated Patients in Mayo Clinic Telestroke Program.
    Demaerschalk BM; Boyd EL; Barrett KM; Gamble DM; Sonchik S; Comer MM; Wieser J; Hentz JG; Fitz-Patrick D; Chang YH
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2940-2942. PubMed ID: 30146388
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World.
    Suzuki J; Nakai N; Kondo N; Tsuji H; Inagaki R; Furukawa S; Iwata M; Nishida S; Ito Y
    Cerebrovasc Dis; 2018; 46(3-4):184-192. PubMed ID: 30384371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.